- Dr. Rainier van Roessel was re-elected Chairman and confirmed for a four-year Supervisory Board term; he joined the board in 2022 and has chaired it since May 2024.
- He began his career at Bayer and served on LANXESS's Executive Board as Labor Director from 2007 until stepping down at the end of 2019.
- Uta Kemmerich-Keil (59) was elected to the Supervisory Board; she most recently led Procter & Gamble's International Personal Healthcare business.
- Dr. Heike Hanagarth, a shareholder representative on the Supervisory Board since 2016, did not stand for re-election.
Supervisory Board leadership
Dr. Rainier van Roessel was re-elected Chairman of LANXESS AG’s Supervisory Board and confirmed by shareholders for another four-year term; he has chaired the board since May 2024 and joined it in 2022.
Professional background
Van Roessel holds a doctorate in business administration, began his career at Bayer AG, joined LANXESS at its founding in 2004, served as Labor Director and Executive Board member from 2007 and stepped down from the Executive Board at the end of 2019.
Board change
Uta Kemmerich-Keil (59) was elected to the Supervisory Board; she most recently led Procter & Gamble’s International Personal Healthcare business and brings extensive operational management experience in healthcare and consumer goods, succeeding Dr. Heike Hanagarth, who did not stand for re-election after serving as a shareholder representative since 2016.
